Esperion Therapeutics
ESPR
#6392
Rank
A$1.13 B
Marketcap
A$4.75
Share price
-3.45%
Change (1 day)
66.12%
Change (1 year)

Market capitalization of Esperion Therapeutics (ESPR)

Market cap: A$1.13 Billion

As of February 2026 Esperion Therapeutics has a market cap of A$1.13 Billion. This makes Esperion Therapeutics the world's 6392th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Esperion Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026A$1.13 B-20.65%
2025A$1.42 B97.98%
2024A$0.72 B44.72%
2023A$0.49 B-26.02%
2022A$0.67 B60.61%
2021A$0.42 B-52.07%
2020A$0.87 B-62.58%
2019A$2.34 B33.71%
2018A$1.75 B-20.72%
2017A$2.20 B463.99%
2016A$0.39 B-43.06%
2015A$0.68 B-31.56%
2014A$1.00 B325.39%
2013A$0.23 B

End of Day market cap according to different sources

On Feb 22nd, 2026 the market cap of Esperion Therapeutics was reported to be:

A$1.17 Billion
by Nasdaq info icon info icon
A$1.17 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
A$216.91 B 19,018.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$117.57 B 10,262.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
A$3.12 B 175.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
A$0.87 B-22.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
A$6.35 B 460.23%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$17.56 B 1,448.39%๐Ÿ‡บ๐Ÿ‡ธ USA